Literature DB >> 20678296

Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony.

V Adaui1, K Schnorbusch, M Zimic, A Gutiérrez, S Decuypere, M Vanaerschot, S DE Doncker, I Maes, A Llanos-Cuentas, F Chappuis, J Arévalo, J-C Dujardin.   

Abstract

INTRODUCTION: Evaluation of Leishmania drug susceptibility depends on in vitro Sb(V) susceptibility assays, which are labour-intensive and may give a biased view of the true parasite resistance. Molecular markers are urgently needed to improve and simplify the monitoring of Sb(V)-resistance. We analysed here the gene expression profile of 21 L. braziliensis clinical isolates in vitro defined as Sb(V)-resistant and -sensitive, in order to identify potential resistance markers.
METHODS: The differential expression of 13 genes involved in Sb(V) metabolism, oxidative stress or housekeeping functions was analysed during in vitro promastigote growth.
RESULTS: Expression profiles were up-regulated for 5 genes only, each time affecting a different set of isolates (mosaic picture of gene expression). Two genes, ODC (ornithine decarboxylase) and TRYR (trypanothione reductase), showed a significantly higher expression rate in the group of Sb(V)-resistant compared to the group of Sb(V)-sensitive parasites (P<0.01). However, analysis of individual isolates showed both markers to explain only partially the drug resistance. DISCUSSION: Our results might be explained by (i) the occurrence of a pleiotropic molecular mechanism leading to the in vitro Sb(V) resistance and/or (ii) the existence of different epi-phenotypes not revealed by the in vitro Sb(V) susceptibility assays, but interfering with the gene expression patterns.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678296     DOI: 10.1017/S0031182010001095

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  19 in total

1.  Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.

Authors:  Dhiraj Kumar; Ruchi Singh; Vasundhra Bhandari; Arpita Kulshrestha; Narendra Singh Negi; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  J-binding protein 1 and J-binding protein 2 expression in clinical Leishmania major no response-antimonial isolates.

Authors:  Salman Ahmadian; Gilda Eslami; Ali Fatahi; Saeede Sadat Hosseini; Mahmoud Vakili; Vahid Ajamein Fahadan; Mourad Elloumi
Journal:  J Parasit Dis       Date:  2018-11-20

Review 3.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

4.  Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

Authors:  Tim Downing; Hideo Imamura; Saskia Decuypere; Taane G Clark; Graham H Coombs; James A Cotton; James D Hilley; Simonne de Doncker; Ilse Maes; Jeremy C Mottram; Mike A Quail; Suman Rijal; Mandy Sanders; Gabriele Schönian; Olivia Stark; Shyam Sundar; Manu Vanaerschot; Christiane Hertz-Fowler; Jean-Claude Dujardin; Matthew Berriman
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

Review 5.  Leishmania antimony resistance: what we know what we can learn from the field.

Authors:  Khatima Aït-Oudhia; Elodie Gazanion; Baptiste Vergnes; Bruno Oury; Denis Sereno
Journal:  Parasitol Res       Date:  2011-07-29       Impact factor: 2.289

6.  Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.

Authors:  Fakhri Jeddi; Charles Mary; Karim Aoun; Zoubir Harrat; Aïda Bouratbine; Françoise Faraut; Rezika Benikhlef; Christelle Pomares; Francine Pratlong; Pierre Marty; Renaud Piarroux
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

7.  Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.

Authors:  Joana Cunha; Eugenia Carrillo; Carmen Sánchez; Israel Cruz; Javier Moreno; Anabela Cordeiro-da-Silva
Journal:  Parasit Vectors       Date:  2013-04-26       Impact factor: 3.876

8.  Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates.

Authors:  Vanessa Adaui; Denis Castillo; Mirko Zimic; Andres Gutierrez; Saskia Decuypere; Manu Vanaerschot; Simonne De Doncker; Kathy Schnorbusch; Ilse Maes; Gert Van der Auwera; Louis Maes; Alejandro Llanos-Cuentas; Jorge Arevalo; Jean-Claude Dujardin
Journal:  PLoS Negl Trop Dis       Date:  2011-05-10

9.  Antimony resistance in leishmania, focusing on experimental research.

Authors:  Fakhri Jeddi; Renaud Piarroux; Charles Mary
Journal:  J Trop Med       Date:  2011-11-17

10.  Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony.

Authors:  Anabel Zabala-Peñafiel; Geovane Dias-Lopes; Léa Cysne-Finkelstein; Fátima Conceição-Silva; Luciana de Freitas Campos Miranda; Aline Fagundes; Armando de Oliveira Schubach; Maria Inês Fernandes Pimentel; Franklin Souza-Silva; Lucas de Almeida Machado; Carlos Roberto Alves
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.